title: Case with chronic myeloid leukemia and T315I mutation, but still in complete molecular response under high dose imatinib therapy.
authors.affiliation: Cathedra of Hematology, Hospital de Clínicas , Montevideo , Uruguay.
authors.forename: Maria Isabel
authors.initials: MI
authors.lastname: Moro
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Manrique
authors.forename: Rosario
authors.initials: R
authors.lastname: Uriarte
authors.forename: Lilián
authors.initials: L
authors.lastname: Díaz
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl